“APR-246 Enhances the Anticancer Effect of Doxorubicin Against p53-Mutant AsPC-1 Pancreatic Cancer Cells”. 2024. Baghdad Science Journal 21 (8): 2551. https://doi.org/10.21123/bsj.2024.10135.